EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Risk of meningococcal infection for children with different hla phenotypes



Risk of meningococcal infection for children with different hla phenotypes



Zhurnal Mikrobiologii Epidemiologii i Immunobiologii (1): 54-56



A total of 104 children (aged 4 mo. to 13 yr) with meningococcal infection were examined. For control, 600 healthy donors were used. Histocompatibility antigens were determined by the lymphotoxic test. Altogether, 36 antigens of the loci A, B and C were determined. Evidently, the risk of contracting this infection is 6 times greater for persons with HLA-Bw16 phenotype and 3 times greater for persons with HLA-A12 phenotype than for persons with HLA-A1 phenotype.

(PDF 0-2 workdays service: $29.90)

Accession: 006345634

Download citation: RISBibTeXText



Related references

Risk of meningococcal infection in children with different hla phenotypes. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii: 54-56, 1981

Determining the level of antibodies to meningococcal antigens in generalized serogroup b meningococcal infection in children. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii (9): 122-123, 1990

Recommendation of the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MenACWY-D) among children aged 9 through 23 months at increased risk for invasive meningococcal disease. Mmwr. Morbidity and Mortality Weekly Report 60(40): 1391-1392, 2011

Recommendation from the advisory committee on immunization practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease. 2007

Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children. Pediatric Infectious Disease Journal 29(7): 618-623, 2010

Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011. Mmwr. Morbidity and Mortality Weekly Report 60(30): 1018-1019, 2011

Infection risk in meningococcal infection (the effect of the duration and closeness of the contact in transmission of the Meningococcus. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii: 20-25, 1975

Some aspects of humoral immunity in meningococcal infection 2. formation of antibodies to group a meningococci in adult patients with generalized meningococcal infection. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii (7): 59-63, 1981

Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates. Clinical and Vaccine Immunology 18(3): 483-486, 2011

How best to describe the risk of meningococcal B infection?. Paediatrics & Child Health 18(10): 543-544, 2014

Meningococcal infection in children. Pediatriia: 10-13, 1976

The course of meningococcal infection in children. Voprosy Okhrany Materinstva i Detstva 21(10): 13-16, 1976

Course of meningococcal infection in children. Voprosy Okhrany Materinstva i Detstva 21(10): 13-16, 1976

Risk of meningococcal infection in college students. JAMA 281(20): 1906-1910, 1999

Clinical course of meningococcal infection in children. Pediatriya (Moscow) 4: 83, 1977